Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:51 UTC |
---|
HMDB ID | HMDB0015067 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Tipranavir |
---|
Description | Tipranavir is only found in individuals that have used or taken this drug. It is a sulfonamide-containing dyhydropyrone and a nonpeptidic protease inhibitor that targets the HIV protease. It is administered with ritonavir in combination therapy to treat HIV infections.Tipranavir inhibits the processing of the viral Gag and Gag-Pol polyproteins in HIV-1 infected cells, thus preventing formation of mature virions. Two mechanisms are suggested in regards to the potency of tipranavir: 1. Tipravanir may bind to the active site of the protease enzyme with fewer hydrogen bonds than peptidic protease inhibitors, which results in increased flexibility, allowing it to fit into the active site of the enzyme in viruses that have become resistance to other protease inhibitors. This also enables tipranavir to adjust to amino acid substitutions at the active site. 2. Tipranavir's strong hydrogen bonding interaction with the amide backbone of the protease active site Asp30 may lead to its activity against resistant viruses. |
---|
Structure | CCC[C@@]1(CCC2=CC=CC=C2)CC(=O)C([C@H](CC)C2=CC(NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)=CC=C2)=C(O)O1 InChI=1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,36,38H,3-4,15-17,19H2,1-2H3/t25-,30-/m1/s1 |
---|
Synonyms | Value | Source |
---|
TPV | HMDB | N-{3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3,4-dihydro-2H-pyran-5-yl]propyl]phenyl}-5-(trifluoromethyl)pyridine-2-sulphonamide | Generator |
|
---|
Chemical Formula | C31H33F3N2O5S |
---|
Average Molecular Weight | 602.664 |
---|
Monoisotopic Molecular Weight | 602.206227481 |
---|
IUPAC Name | N-{3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3,4-dihydro-2H-pyran-5-yl]propyl]phenyl}-5-(trifluoromethyl)pyridine-2-sulfonamide |
---|
Traditional Name | aptivus |
---|
CAS Registry Number | 174484-41-4 |
---|
SMILES | CCC[C@@]1(CCC2=CC=CC=C2)CC(=O)C([C@H](CC)C2=CC(NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)=CC=C2)=C(O)O1 |
---|
InChI Identifier | InChI=1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,36,38H,3-4,15-17,19H2,1-2H3/t25-,30-/m1/s1 |
---|
InChI Key | NZPXPXAGXYTROM-FYBSXPHGSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as linear diarylheptanoids. These are diarylheptanoids with an open heptane chain. The two aromatic rings are linked only by the heptane chain. |
---|
Kingdom | Organic compounds |
---|
Super Class | Phenylpropanoids and polyketides |
---|
Class | Diarylheptanoids |
---|
Sub Class | Linear diarylheptanoids |
---|
Direct Parent | Linear diarylheptanoids |
---|
Alternative Parents | |
---|
Substituents | - Linear 1,7-diphenylheptane skeleton
- Sulfanilide
- Pyridine-2-sulfonamide
- Phenylpropane
- Dihydropyranone
- Monocyclic benzene moiety
- Organosulfonic acid amide
- Benzenoid
- Pyridine
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Sulfonyl
- Vinylogous ester
- Vinylogous acid
- Heteroaromatic compound
- Aminosulfonyl compound
- Ketene acetal or derivatives
- Ketone
- Cyclic ketone
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organofluoride
- Organohalogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Carbonyl group
- Organic nitrogen compound
- Alkyl fluoride
- Alkyl halide
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.00021 g/L | Not Available | LogP | 6.9 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Tipranavir,1TMS,isomer #1 | CCC[C@@]1(CCC2=CC=CC=C2)CC(=O)C([C@H](CC)C2=CC=CC(NS(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C)O1 | 3808.4 | Semi standard non polar | 33892256 | Tipranavir,1TMS,isomer #2 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C)C([C@H](CC)C2=CC=CC(NS(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O)O1 | 3889.8 | Semi standard non polar | 33892256 | Tipranavir,1TMS,isomer #3 | CCC[C@@]1(CCC2=CC=CC=C2)CC(=O)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O)O1 | 3884.9 | Semi standard non polar | 33892256 | Tipranavir,2TMS,isomer #1 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C)C([C@H](CC)C2=CC=CC(NS(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C)O1 | 3805.9 | Semi standard non polar | 33892256 | Tipranavir,2TMS,isomer #1 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C)C([C@H](CC)C2=CC=CC(NS(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C)O1 | 3685.9 | Standard non polar | 33892256 | Tipranavir,2TMS,isomer #1 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C)C([C@H](CC)C2=CC=CC(NS(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C)O1 | 4743.6 | Standard polar | 33892256 | Tipranavir,2TMS,isomer #2 | CCC[C@@]1(CCC2=CC=CC=C2)CC(=O)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C)O1 | 3771.5 | Semi standard non polar | 33892256 | Tipranavir,2TMS,isomer #2 | CCC[C@@]1(CCC2=CC=CC=C2)CC(=O)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C)O1 | 3909.9 | Standard non polar | 33892256 | Tipranavir,2TMS,isomer #2 | CCC[C@@]1(CCC2=CC=CC=C2)CC(=O)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C)O1 | 4655.8 | Standard polar | 33892256 | Tipranavir,2TMS,isomer #3 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O)O1 | 3843.5 | Semi standard non polar | 33892256 | Tipranavir,2TMS,isomer #3 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O)O1 | 3869.6 | Standard non polar | 33892256 | Tipranavir,2TMS,isomer #3 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O)O1 | 4877.5 | Standard polar | 33892256 | Tipranavir,3TMS,isomer #1 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C)O1 | 3771.4 | Semi standard non polar | 33892256 | Tipranavir,3TMS,isomer #1 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C)O1 | 3823.9 | Standard non polar | 33892256 | Tipranavir,3TMS,isomer #1 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C)O1 | 4563.6 | Standard polar | 33892256 | Tipranavir,1TBDMS,isomer #1 | CCC[C@@]1(CCC2=CC=CC=C2)CC(=O)C([C@H](CC)C2=CC=CC(NS(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C(C)(C)C)O1 | 3978.8 | Semi standard non polar | 33892256 | Tipranavir,1TBDMS,isomer #2 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C(C)(C)C)C([C@H](CC)C2=CC=CC(NS(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O)O1 | 4067.3 | Semi standard non polar | 33892256 | Tipranavir,1TBDMS,isomer #3 | CCC[C@@]1(CCC2=CC=CC=C2)CC(=O)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O)O1 | 4048.4 | Semi standard non polar | 33892256 | Tipranavir,2TBDMS,isomer #1 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C(C)(C)C)C([C@H](CC)C2=CC=CC(NS(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C(C)(C)C)O1 | 4129.5 | Semi standard non polar | 33892256 | Tipranavir,2TBDMS,isomer #1 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C(C)(C)C)C([C@H](CC)C2=CC=CC(NS(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C(C)(C)C)O1 | 4051.9 | Standard non polar | 33892256 | Tipranavir,2TBDMS,isomer #1 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C(C)(C)C)C([C@H](CC)C2=CC=CC(NS(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C(C)(C)C)O1 | 4791.8 | Standard polar | 33892256 | Tipranavir,2TBDMS,isomer #2 | CCC[C@@]1(CCC2=CC=CC=C2)CC(=O)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C(C)(C)C)O1 | 4103.9 | Semi standard non polar | 33892256 | Tipranavir,2TBDMS,isomer #2 | CCC[C@@]1(CCC2=CC=CC=C2)CC(=O)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C(C)(C)C)O1 | 4351.1 | Standard non polar | 33892256 | Tipranavir,2TBDMS,isomer #2 | CCC[C@@]1(CCC2=CC=CC=C2)CC(=O)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O[Si](C)(C)C(C)(C)C)O1 | 4671.7 | Standard polar | 33892256 | Tipranavir,2TBDMS,isomer #3 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C(C)(C)C)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O)O1 | 4171.9 | Semi standard non polar | 33892256 | Tipranavir,2TBDMS,isomer #3 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C(C)(C)C)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O)O1 | 4283.4 | Standard non polar | 33892256 | Tipranavir,2TBDMS,isomer #3 | CCC[C@@]1(CCC2=CC=CC=C2)C=C(O[Si](C)(C)C(C)(C)C)C([C@H](CC)C2=CC=CC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C3=CC=C(C(F)(F)F)C=N3)=C2)=C(O)O1 | 4873.7 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Tipranavir GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-8229270000-596bf0ee34438763294c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tipranavir GC-MS (1 TMS) - 70eV, Positive | splash10-01po-5405229000-1fdb1b5902795e4e97e8 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tipranavir GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tipranavir GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tipranavir GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tipranavir GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tipranavir GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tipranavir GC-MS ("Tipranavir,1TMS,#1" TMS) - 70eV, Positive | Not Available | 2021-10-20 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tipranavir 10V, Positive-QTOF | splash10-0fc3-2329435000-8b161c5b43dec5b7d624 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tipranavir 20V, Positive-QTOF | splash10-0a4i-2915000000-3450510ad42cdf51646b | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tipranavir 40V, Positive-QTOF | splash10-0006-9803000000-88c9b757103b61b820b1 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tipranavir 10V, Negative-QTOF | splash10-0pb9-0420093000-e07ea9e6e3ce13fce6a0 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tipranavir 20V, Negative-QTOF | splash10-0a4i-0491131000-9be133ee8ba218c4652c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tipranavir 40V, Negative-QTOF | splash10-000j-4910100000-68f43304d077d485af49 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tipranavir 10V, Positive-QTOF | splash10-0udi-2000109000-7b162ab71992fa9cc908 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tipranavir 20V, Positive-QTOF | splash10-0f6x-7801496000-795a6c06736141d22924 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tipranavir 40V, Positive-QTOF | splash10-0aor-2911000000-ca162651cff1ff6ea328 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tipranavir 10V, Negative-QTOF | splash10-0udi-0000009000-f2dc818653fae19f83bf | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tipranavir 20V, Negative-QTOF | splash10-0udi-2210389000-b8011d98164d3a715210 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tipranavir 40V, Negative-QTOF | splash10-0006-2409430000-a5306ead0a49ae4cd0aa | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|